imatinib has been researched along with Acute Myelogenous Leukemia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Peng, H | 1 |
| Huang, N | 1 |
| Qi, J | 1 |
| Xie, P | 1 |
| Xu, C | 1 |
| Wang, J | 1 |
| Yang, C | 1 |
| Page, BD | 1 |
| Khoury, H | 1 |
| Laister, RC | 1 |
| Fletcher, S | 1 |
| Vellozo, M | 1 |
| Manzoli, A | 1 |
| Yue, P | 1 |
| Turkson, J | 1 |
| Minden, MD | 1 |
| Gunning, PT | 1 |
| Heidary, DK | 1 |
| Huang, G | 1 |
| Boucher, D | 1 |
| Ma, J | 1 |
| Forster, C | 1 |
| Grey, R | 1 |
| Xu, J | 1 |
| Arnost, M | 1 |
| Choquette, D | 1 |
| Chen, G | 1 |
| Zhou, JH | 1 |
| Yao, YM | 1 |
| Ball, ED | 1 |
| Namchuk, M | 1 |
| Davies, RJ | 1 |
| Henkel, G | 1 |
| Romagnoli, R | 1 |
| Baraldi, PG | 1 |
| Prencipe, F | 1 |
| Lopez-Cara, C | 1 |
| Rondanin, R | 1 |
| Simoni, D | 1 |
| Hamel, E | 1 |
| Grimaudo, S | 1 |
| Pipitone, RM | 1 |
| Meli, M | 1 |
| Tolomeo, M | 1 |
| Klaeger, S | 1 |
| Heinzlmeir, S | 1 |
| Wilhelm, M | 1 |
| Polzer, H | 1 |
| Vick, B | 1 |
| Koenig, PA | 1 |
| Reinecke, M | 1 |
| Ruprecht, B | 1 |
| Petzoldt, S | 1 |
| Meng, C | 1 |
| Zecha, J | 1 |
| Reiter, K | 1 |
| Qiao, H | 1 |
| Helm, D | 1 |
| Koch, H | 1 |
| Schoof, M | 1 |
| Canevari, G | 1 |
| Casale, E | 1 |
| Depaolini, SR | 1 |
| Feuchtinger, A | 1 |
| Wu, Z | 1 |
| Schmidt, T | 1 |
| Rueckert, L | 1 |
| Becker, W | 1 |
| Huenges, J | 1 |
| Garz, AK | 1 |
| Gohlke, BO | 1 |
| Zolg, DP | 1 |
| Kayser, G | 1 |
| Vooder, T | 1 |
| Preissner, R | 1 |
| Hahne, H | 1 |
| Tõnisson, N | 1 |
| Kramer, K | 1 |
| Götze, K | 1 |
| Bassermann, F | 1 |
| Schlegl, J | 1 |
| Ehrlich, HC | 1 |
| Aiche, S | 1 |
| Walch, A | 1 |
| Greif, PA | 1 |
| Schneider, S | 1 |
| Felder, ER | 1 |
| Ruland, J | 1 |
| Médard, G | 1 |
| Jeremias, I | 1 |
| Spiekermann, K | 1 |
| Kuster, B | 1 |
| Lin, WH | 1 |
| Wu, SY | 1 |
| Yeh, TK | 1 |
| Chen, CT | 1 |
| Song, JS | 1 |
| Shiao, HY | 1 |
| Kuo, CC | 1 |
| Hsu, T | 1 |
| Lu, CT | 1 |
| Wang, PC | 1 |
| Wu, TS | 1 |
| Peng, YH | 1 |
| Lin, HY | 1 |
| Chen, CP | 1 |
| Weng, YL | 1 |
| Kung, FC | 1 |
| Wu, MH | 1 |
| Su, YC | 1 |
| Huang, KW | 1 |
| Chou, LH | 1 |
| Hsueh, CC | 1 |
| Yen, KJ | 1 |
| Kuo, PC | 1 |
| Huang, CL | 1 |
| Chen, LT | 1 |
| Shih, C | 1 |
| Tsai, HJ | 1 |
| Jiaang, WT | 1 |
| Marín-Rubio, JL | 1 |
| Peltier-Heap, RE | 1 |
| Dueñas, ME | 1 |
| Heunis, T | 1 |
| Dannoura, A | 1 |
| Inns, J | 1 |
| Scott, J | 1 |
| Simpson, AJ | 1 |
| Blair, HJ | 1 |
| Heidenreich, O | 1 |
| Allan, JM | 1 |
| Watt, JE | 1 |
| Martin, MP | 1 |
| Saxty, B | 1 |
| Trost, M | 1 |
7 other studies available for imatinib and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Identification of novel inhibitors of BCR-ABL tyrosine kinase via virtual screening.
Topics: Binding Sites; Computer Simulation; Databases, Genetic; Drug Evaluation, Preclinical; Enzyme Inhibit | 2003 |
Small molecule STAT5-SH2 domain inhibitors exhibit potent antileukemia activity.
Topics: Aminosalicylic Acids; Antineoplastic Agents; Binding, Competitive; Cell Line, Tumor; Drug Screening | 2012 |
VX-322: a novel dual receptor tyrosine kinase inhibitor for the treatment of acute myelogenous leukemia.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Survival; fms-Like Tyrosine Kinase 3; Humans; Leukem | 2012 |
Novel iodoacetamido benzoheterocyclic derivatives with potent antileukemic activity are inhibitors of STAT5 phosphorylation.
Topics: Antineoplastic Agents; Apoptosis; Benzofurans; Benzophenones; Cell Proliferation; Dose-Response Rela | 2016 |
The target landscape of clinical kinase drugs.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cytokines; Drug Discovery; fms-Like Tyrosine Kinas | 2017 |
Identification of a Multitargeted Tyrosine Kinase Inhibitor for the Treatment of Gastrointestinal Stromal Tumors and Acute Myeloid Leukemia.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Female; fms-Like Tyrosine Kinase 3; G | 2019 |
A Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Assay Identifies Nilotinib as an Inhibitor of Inflammation in Acute Myeloid Leukemia.
Topics: Cytokines; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Inflammat | 2022 |